Pharma Commons
  • Home
  • About
  • Company List
  • Contact

Bayer commences phase III trial of hemophilia drug

July 8, 2012 PBR - Clinical Trials News Bayer
Bayer Health Care has commenced the enrollment of patients for an international Phase III trial to study its investigational compound BAY94-9027, used to treat hemophilia A.
Read the full story: PBR - Clinical Trials News

Post navigation

Covidien brain device elicits FDA warning (Weekend Rounds)
Merck KGaA Licenses Versamune Platform

Receive a daily news digest

Enter your email address:

Search the archive

Search for:

Company list

Browse by tags

Abbott abbott laboratories Amgen astrazeneca astrazeneca plc Bayer biogen idec boehringer ingelheim breast cancer bristol myers bristol myers squibb bristol myers squibb company cancer drug diabetes drug eli lilly eli lilly and company food and drug administration genepool gilead sciences gilead sciences inc glaxosmithkline glaxosmithkline plc gsk latest biotech news Lilly lilly and company london reuters Merck merck kgaa merck serono Myers Nordisk Novartis novartis ag novo nordisk pfizer pfizer inc Pharma PLC PRNewswire reuters Roche roche holding ag rsquo sanofi
dazzling Theme by Colorlib Powered by WordPress